Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Dominic De Groote
Profile
Projects
Publications
Activities
Awards & Distinctions
Results
:
ALL
(
31
)
Order By :
Chronological by starting year (new to old)
Title (a-z)
Chronological by starting year (new to old)
As
Promotor
01 October 2020 → 30 September 2025
DiscoverE
Funding: Regional and community funding: Industrial Research Fund
01 October 2020 → 30 September 2024
Promoting intestinal health by modulating the Zinc-microbiome axis at the Paneth cell level (acronym: ZIPAM)
Funding: Research Foundation - Flanders (FWO)
01 October 2019 → 30 June 2025
CleanChem
Funding: Regional and community funding: Industrial Research Fund
As
Copromotor
15 July 2023 → 14 February 2025
Increasing the value proposition of the IOF programs CRISParray and Amalus: CRISPRi-based target deconvolution of fibroblast modulators
Funding: Regional and community funding: Industrial Research Fund
01 October 2021 → 30 September 2025
STOP_SEPSIS: investigation into a new concept of sepsis, the greatest unmet medical need of our times.
Funding: Research Foundation - Flanders (FWO)
01 October 2021 → 30 September 2025
Targeting transcription factor addiction in acute leukemia (TaTFAL)
Funding: Research Foundation - Flanders (FWO)
01 January 2015 → 31 December 2017
Unravelling the pharmaceutical potential of receptor heterodimers for therapeutic intervention in CNS disorders.
Funding: Regional and community funding: various
01 September 2014 → 31 December 2016
An Opportunity to Develop Novel Inhibitors of Invasion for the Treatment of Metastatic Cancers
Funding: Regional and community funding: Industrial Research Fund
15 August 2014 → 31 March 2018
Exploiting novel GR biology as an opportunity to develop safer anti-inflammatory drugs
Funding: Regional and community funding: Industrial Research Fund
15 August 2014 → 15 August 2017
Opportunity to develop novel HDAC6 inhibitors for therapeutic use
Funding: Regional and community funding: Industrial Research Fund
01 January 2013 → 31 December 2016
Fighting infectious diseases with combination therapy: targetting sociomicrobiological processes to circumvent antimicrobial resistance
Funding: Regional and community funding: various
01 August 2012 → 30 April 2014
Hit-to-lead Evaluation of Chalcone Analogs Useful for Anti-Invasive Cancer Therapy
Funding: Regional and community funding: Industrial Research Fund
01 January 2012 → 31 December 2015
STRETCH: mechanotransduction in osteoimmunology: an innovative approach towards effective drug for rheumatic diseases
Funding: Regional and community funding: various
01 January 2011 → 31 December 2014
Circumventing the Biological Obstacles of anti-inflammatory Glucocorticoid Therapy
Funding: Regional and community funding: various
As
Business Developer
20 December 2023 → 14 January 2026
Development of an innovative Fentanyl vaccine
Funding: Regional and community funding: Industrial Research Fund
16 October 2023 → 31 December 2024
Evaluation of a new treatment against "blackhead" disease in turkeys (POULTRY 2)
Funding: Regional and community funding: Industrial Research Fund
15 July 2023 → 14 October 2024
Identification of optimized Aurora Kinase A PROTACs with suitable PK properties for in vivo proof-of-concept studies (OPTIMAPK).
Funding: Regional and community funding: Industrial Research Fund
15 July 2023 → 14 February 2025
Increasing the value proposition of the IOF programs CRISParray and Amalus: CRISPRi-based target deconvolution of fibroblast modulators
Funding: Regional and community funding: Industrial Research Fund
15 April 2023 → 14 April 2024
TARgeted Mrna re-engineering for enhanced Antibody and Cellular immunity (TARMAC)
Funding: Regional and community funding: Industrial Research Fund
01 November 2022 → 30 April 2025
Introducing mRNA vaccination in chicken: first steps towards a commercial mRNA vaccine against a leading viral infection in chicken
Funding: Regional and community funding: Industrial Research Fund
15 July 2022 → 14 February 2025
Validation of a small molecule system for a safer treatment of chronic inflammation
Funding: Regional and community funding: Industrial Research Fund
15 April 2022 → 31 December 2024
The generation of bona fide T cell precursors for cell therapy
Funding: Regional and community funding: Industrial Research Fund
15 October 2021 → 30 September 2023
Extending the Amalus drug discovery program: validation studies for immuno-oncological and fibrosis indications to increase the IP and investment value
Funding: Regional and community funding: Industrial Research Fund
01 October 2021 → 30 September 2023
IonKey/MSTM system: enhanced ‘plug and play’ mass spectrometry for ultrasensitive quantification of small molecules in small sample volumes in life sciences, with applications in the development and valorisation of endotoxin-mitigation strategies (feed additives) and anti-inflammatory drugs (pharma) in livestock.
Funding: Regional and community funding: Industrial Research Fund
15 July 2021 → 14 July 2022
An innovative class of ionizable lipids for use in lipid nanoparticle based RNA therapeutics and vaccines
Funding: Regional and community funding: Industrial Research Fund
15 July 2021 → 30 June 2025
BioGelator for local immunotherapy
Funding: Regional and community funding: Industrial Research Fund
15 June 2020 → 28 February 2022
Accellerating towards clinical validation of Galsome nanovaccines
Funding: Regional and community funding: Industrial Research Fund
01 August 2019 → 31 March 2022
Mechanistic & Empirical Modeling for the PHarmaceutical InduStry
Funding: Regional and community funding: Industrial Research Fund
01 April 2019 → 31 August 2020
IP strenghtening for MIDRIX, a unique manufacturing process for dendritic cell immunotherapy in solid cancers
Funding: Regional and community funding: Industrial Research Fund
01 April 2019 → 31 March 2020
Strengthening the UGent patent position on an improved cultivation method for adoptive cell therapies (immuno-oncology).
Funding: Regional and community funding: Industrial Research Fund
01 August 2018 → 28 February 2023
A SMART technology for the continuous manufacturing of lyophilized orally disintegrating tablets
Funding: Regional and community funding: Industrial Research Fund